FeesSafety
Pluang+

Wave Life Sciences downgraded to Hold due to limited near-term growth and competitive market pressures.

Analyst Insights
10 Nov 2026, 20:55 WIB
Seeking Alpha
View Source
Bearish
Wave Life Sciences downgraded to Hold due to limited near-term growth and competitive market pressures.

Wave Life Sciences has been downgraded from Buy to Hold as its obesity drug WVE-007 shows modest weight loss results, lagging behind competitors. The upcoming data for WVE-006 in AATD is a key catalyst, with potential for accelerated approval. Despite a strong cash position and a partnership with GSK, concerns remain over high cash burn and challenges in the RNAi sector, leading to cautious outlook on the stock.

Wave Life Sciences and its near-term AATD catalyst are presented here with Pluang's Health-sector snapshot as of Nov 11, 2026 01:11 WIB: Among 150 priced US Health stocks, 39 rose and 110 fell. American Well Corp (AMWL) dropped 5.62% to USD 11.76 with 94% of Pluang orders selling, contrasting with Canopy Growth Corp (CGC) at USD 0.59 which saw a full 100% buy activity despite a 5.27% decline. Abeona Therapeutics Inc (ABEO) hovered near even with a 5.31% drop and balanced buy-sell orders.

More News

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
1 hour ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
1 hour ago
Pepeto presale nears sellout with $11.29M raised as XRP price targets $27 amid recent dip.

Pepeto presale nears sellout with $11.29M raised as XRP price targets $27 amid recent dip.

Pepeto's crypto presale is close to selling out, having raised $11.29 million with over 43,000 holders, driven by its fee-free trading platform and AI contract checks. Meanwhile, XRP's price has dropped to $1.11, down 72% from its peak, but analysts ...

Market News
Neutral
1 hour ago
YieldMax ETFs announce weekly distributions for Group 1 ETFs with rates up to 60%.

YieldMax ETFs announce weekly distributions for Group 1 ETFs with rates up to 60%.

YieldMax ETFs declared weekly distributions for their Group 1 ETFs, with distribution rates ranging from about 20% to 60% annually, depending on the ETF. These distributions reflect income generated primarily from options strategies and vary signific...

Neutral
1 hour ago
EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App